The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT01061060
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 110 participants
- Registry
-
NCT01061060
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01061060. Randomized; quadruple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2010-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Peripheral Microvascular Symptoms
- Intervention (Drug)
- Prostaglandin I2
- Intervention (Drug)
- Placebo
- Lead sponsor
- Yonsei University
- Collaborator
- Astellas Pharma Korea, Inc.
Record details
- Record id
cardio:ct-nct01061060- Content hash
650bdec53af29e60255dc51dac8cf86111bf5e54609cb34a903eeec4053227aa